Skip to main content
Erschienen in: Annals of Surgical Oncology 6/2018

09.04.2018 | Gastrointestinal Oncology

Efficacy of Endoscopic Management for Early Remnant Gastric Cancer: Is Completion Gastrectomy Truly Necessary in Cases with Marginally Noncurative Histopathologic Features?

verfasst von: Yudai Fukui, MD, Junichi Shindoh, MD, PhD, Naoko Inoshita, MD, PhD, Aya Mizuno, MD, Shusuke Haruta, MD, PhD, Harushi Udagawa, MD, PhD, Shu Hoteya, MD, PhD, Shigeru Tsunoda, MD, PhD, Shin’ichi Miyamoto, MD, PhD, Rie Ozawa, MD, Hirotaka Niwa, MD, PhD, Yoshiharu Sakai, MD, PhD, Hisashi Shinohara, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

For patients with early primary gastric cancer, endoscopic management has become a standard of care. However, its efficacy for early remnant gastric cancer (ERGC) remains controversial and an invasive surgical procedure remains the primary choice of treatment.

Methods

A multi-institutional database of ERGC cases was retrospectively reviewed. Efficacy of endoscopic resection was analyzed by reviewing the clinicopathologic features of patients who underwent endoscopic resection and comparing the long-term outcomes with those of surgical resection.

Results

Of the 121 patients who were histopathologically diagnosed with ERGC after distal gastrectomy, 80 underwent endoscopic resection and 41 underwent completion gastrectomy (Group S). According to the histopathological criteria, 55 of the 80 endoscopic resection cases were classified as “curative resection” (Group E1) and the remaining 25 were classified as “noncurative resection” (Group E2). Tumor recurrence was observed only in three patients (12%) in Group E2, and no tumor recurrence was confirmed in Group S and Group E1. Multivariate analyses confirmed that completion gastrectomy [hazard ratio (HR), 6.2; 95% confidence interval (CI), 1.5–26.3] was associated with poor survival compared with endoscopic resection, and lymphovascular infiltration (HR 9.5; 95% CI 2.5–36.7) was correlated with tumor recurrence. Histopathological positive resection margin, tumor size, or deeper tumor invasion were not correlated with tumor recurrence after endoscopic resection.

Conclusions

Endoscopic management might be an effective treatment option for ERGC with potential long-term survival advantage over the completion gastrectomy even in cases with histopathological features, suggesting noncurative resection.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat La Vecchia C, Negri E, D’Avanzo B, Moller H, Franceschi S. Partial gastrectomy and subsequent gastric cancer risk. J Epidemiol Community Health. 1992;46(1):12–4.CrossRefPubMedPubMedCentral La Vecchia C, Negri E, D’Avanzo B, Moller H, Franceschi S. Partial gastrectomy and subsequent gastric cancer risk. J Epidemiol Community Health. 1992;46(1):12–4.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Hirasaki S, Kanzaki H, Matsubara M, Fujita K, Matsumura S, Suzuki S. Treatment of gastric remnant cancer post distal gastrectomy by endoscopic submucosal dissection using an insulation-tipped diathermic knife. World J Gastroenterol. 2008;14(16):2550–5.CrossRefPubMedPubMedCentral Hirasaki S, Kanzaki H, Matsubara M, Fujita K, Matsumura S, Suzuki S. Treatment of gastric remnant cancer post distal gastrectomy by endoscopic submucosal dissection using an insulation-tipped diathermic knife. World J Gastroenterol. 2008;14(16):2550–5.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Hoteya S, Iizuka T, Kikuchi D, Yahagi N. Clinical advantages of endoscopic submucosal dissection for gastric cancers in remnant stomach surpass conventional endoscopic mucosal resection. Dig Endosc. 2010;22(1):17–20.CrossRefPubMed Hoteya S, Iizuka T, Kikuchi D, Yahagi N. Clinical advantages of endoscopic submucosal dissection for gastric cancers in remnant stomach surpass conventional endoscopic mucosal resection. Dig Endosc. 2010;22(1):17–20.CrossRefPubMed
4.
Zurück zum Zitat Lee JY, Choi IJ, Cho SJ, Kim CG, Kook MC, Lee JH, et al. Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy. Surg Endosc. 2010;24(6):1360–6.CrossRefPubMed Lee JY, Choi IJ, Cho SJ, Kim CG, Kook MC, Lee JH, et al. Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy. Surg Endosc. 2010;24(6):1360–6.CrossRefPubMed
5.
Zurück zum Zitat Nishide N, Ono H, Kakushima N, Takizawa K, Tanaka M, Matsubayashi H, et al. Clinical outcomes of endoscopic submucosal dissection for early gastric cancer in remnant stomach or gastric tube. Endoscopy. 2012;44(6):577–83.CrossRefPubMed Nishide N, Ono H, Kakushima N, Takizawa K, Tanaka M, Matsubayashi H, et al. Clinical outcomes of endoscopic submucosal dissection for early gastric cancer in remnant stomach or gastric tube. Endoscopy. 2012;44(6):577–83.CrossRefPubMed
6.
Zurück zum Zitat Choi YY, Kwon IG, Lee SK, Kim HK, An JY, Kim HI, et al. Can we apply the same indication of endoscopic submucosal dissection for primary gastric cancer to remnant gastric cancer? Gastric Cancer. 2014;17(2):310–5.CrossRefPubMed Choi YY, Kwon IG, Lee SK, Kim HK, An JY, Kim HI, et al. Can we apply the same indication of endoscopic submucosal dissection for primary gastric cancer to remnant gastric cancer? Gastric Cancer. 2014;17(2):310–5.CrossRefPubMed
7.
Zurück zum Zitat Nonaka S, Oda I, Makazu M, Haruyama S, Abe S, Suzuki H, et al. Endoscopic submucosal dissection for early gastric cancer in the remnant stomach after gastrectomy. Gastrointest Endosc. 2013;78(1):63–72.CrossRefPubMed Nonaka S, Oda I, Makazu M, Haruyama S, Abe S, Suzuki H, et al. Endoscopic submucosal dissection for early gastric cancer in the remnant stomach after gastrectomy. Gastrointest Endosc. 2013;78(1):63–72.CrossRefPubMed
8.
Zurück zum Zitat Yamashina T, Uedo N, Dainaka K, Aoi K, Matsuura N, Ito T, et al. Long-term survival after endoscopic resection for early gastric cancer in the remnant stomach: comparison with radical surgery. Ann Gastroenterol. 2015;28(1):66–71.PubMedPubMedCentral Yamashina T, Uedo N, Dainaka K, Aoi K, Matsuura N, Ito T, et al. Long-term survival after endoscopic resection for early gastric cancer in the remnant stomach: comparison with radical surgery. Ann Gastroenterol. 2015;28(1):66–71.PubMedPubMedCentral
9.
Zurück zum Zitat Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2016. Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2016.
10.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.CrossRefPubMed Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.CrossRefPubMed
11.
Zurück zum Zitat Owens WD, Felts JA, Spitznagel EL, Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology. 1978;49(4):239–43.CrossRefPubMed Owens WD, Felts JA, Spitznagel EL, Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology. 1978;49(4):239–43.CrossRefPubMed
12.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.CrossRefPubMed Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.CrossRefPubMed
13.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Hosokawa Y, Konishi M, Sahara Y, Kinoshita T, Takahashi S, Gotohda N, et al. Limited subtotal gastrectomy for early remnant gastric cancer. Gastric Cancer. 2014;17(2):332–6.CrossRefPubMed Hosokawa Y, Konishi M, Sahara Y, Kinoshita T, Takahashi S, Gotohda N, et al. Limited subtotal gastrectomy for early remnant gastric cancer. Gastric Cancer. 2014;17(2):332–6.CrossRefPubMed
15.
Zurück zum Zitat Irino T, Hiki N, Nunobe S, Ohashi M, Tanimura S, Sano T, et al. Subtotal gastrectomy with limited lymph node dissection is a feasible treatment option for patients with early gastric stump cancer. J Gastrointest Surg. 2014;18(8):1429–33.CrossRefPubMed Irino T, Hiki N, Nunobe S, Ohashi M, Tanimura S, Sano T, et al. Subtotal gastrectomy with limited lymph node dissection is a feasible treatment option for patients with early gastric stump cancer. J Gastrointest Surg. 2014;18(8):1429–33.CrossRefPubMed
Metadaten
Titel
Efficacy of Endoscopic Management for Early Remnant Gastric Cancer: Is Completion Gastrectomy Truly Necessary in Cases with Marginally Noncurative Histopathologic Features?
verfasst von
Yudai Fukui, MD
Junichi Shindoh, MD, PhD
Naoko Inoshita, MD, PhD
Aya Mizuno, MD
Shusuke Haruta, MD, PhD
Harushi Udagawa, MD, PhD
Shu Hoteya, MD, PhD
Shigeru Tsunoda, MD, PhD
Shin’ichi Miyamoto, MD, PhD
Rie Ozawa, MD
Hirotaka Niwa, MD, PhD
Yoshiharu Sakai, MD, PhD
Hisashi Shinohara, MD, PhD
Publikationsdatum
09.04.2018
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6407-8

Weitere Artikel der Ausgabe 6/2018

Annals of Surgical Oncology 6/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.